I. M. Aridana Sandika, M. O. Sastrawan, and N. G. B. Arsa Wibawa, “Does Germline BRCA1/2 Status Modify the Effect of Neoadjuvant Pembrolizumab on Pathological Complete Response in Early-Stage Triple-Negative Breast Cancer? A Systematic Review and Meta-analysis of Treatment-Biomarker Interactions”, Bioscmed, vol. 10, no. 10, pp. 2896–2908, Aug. 2026, doi: 10.37275/bsm.v10i10.1658.